Bears Lurk As Bankers Hike

The Federal Reserve’s 25 bp hike is getting all the attention this week, but several other central banks recently made policy decisions worth noting. 📝

  1. The European Central Bank (ECB) raised rates by 50 bps to 3.00%;
  2. The Swiss National Bank raised rates by 50 bps to 1.50%;
  3. The Bank of England raised rates by 25 bps to 4.25%;
  4. The Bank of Canada held rates at 4.50%;
  5. The Bank of Japan held rates at -0.1%; and
  6. Banco Central do Brasil held rates at 13.75%.

The overarching theme among central banks is that they remain hyper-focused on bringing down inflation. They’re not letting the many market/economic distractions take them off track. With that said, many have slowed their pace of hikes and are nearing their projected terminal rate, where they intend to leave policy to observe how the economy reacts. Additionally, officials have become more optimistic about their economies’ ability to avoid a recession while inflation comes down. ðŸ”Ū

Meanwhile, here in the U.S., concerns over the regional banking crisis remain. Bill Ackman and others have been highly critical of Treasury Secretary Janet Yellen’s recent comments. She said that complete deposit protection for all banks was not being considered. Instead, the government is choosing only to protect deposits at banks that pose a risk of contagion to the system. ðŸĶ

And in Europe, Swiss regulators are facing backlash over UBS’ takeover of Credit Suisse. In particular, Additional Tier 1( AT1) bondholders feel that their investments should not be entirely written down. Others are more concerned about the risk this “mega-bank” could pose to the country, as it’s now twice the size of Switzerland’s economy.

So far, the market’s reactions have been mixed. However, policymakers are staying steady on their hiking path despite the looming bearish sentiment. So, whether it’s central bank decisions or news about private sector banks, the sector will remain in focus for the foreseeable future. 👀

More in   Policy

View All

Fed Cuts Down Bears’ Remaining Hope

We said yesterday that expectations for a dovish Federal Reserve meeting were high. And for now, it appears that Jerome Powell and the FOMC have delivered just that. ðŸĪĐ

The Federal Open Market Committee (FOMC) statement changed slightly vs. November, primarily adding verbiage that “inflation has eased over the past year” but remains elevated. As such, they kept rates unchanged to close out 2023.

Read It

Just A Minute(s)

The Federal Open Market Committee (FOMC) released the meeting minutes from its January 31 to February 1 meeting, where it raised rates by 25 bps. And while previous minutes had shown most members were on the same page about the policy path, there was some contention in this meeting. ⚔ïļ

Most members stressed that inflation remains well above the long-term 2% target and that ongoing rate increases would be necessary. The ultimate question(s) remains how high do rates need to go to be restrictive, how long will they have to stay there, and what path will the Fed take to get there?

Read It

Risks To The Rate Cut Thesis

One of the big themes we’ve discussed for the last four months has been the Fed cutting rates in 2024. However, there’s been a major disconnect between the market’s expectations and the Fed’s guidance since November. That disconnect made today’s Fed decision and commentary tricky for the market to digest. Let’s talk about why. ðŸĪ”

First off, going into this year, the Fed fund futures market was anticipating six rate cuts during 2024. Meanwhile, the Fed’s guidance in December suggested the central bank was estimating just three cuts during the year, as it believes there are still upside risks to inflation.

Read It

Pot Stocks Heat Up

Stocks and ETFs related to the cannabis industry soared today, heating up again despite their habit of disappointing long-term investors. ðŸ”Ĩ

The industry’s renewed interest came after a top official at the Department of Health and Human Services (HHS) recommended easing restrictions on marijuana. The official wrote to the Drug Enforcement Agency (DEA) Administrator Anne Milgram, calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act.

Read It